Clinical study of heyingshui decoction in optimizing anti VEGF treatment of macular edema due to retinal vein occlusion

onghua Hospital Affiliated to Shanghai University of traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) The macular fovea thickness was more than or equal to 300um.
•(2) It is in accordance with the diagnostic criteria of TCM syndrome of blood stasis obstructing collaterals and water dampness stopping inside.
•(3) They are between 25 and 80 years old.
•(4) In our hospital, no other traditional Chinese medicine, macular grid photocoagulation, intravitreal drug injection or vitrectomy were taken.

•(1) Patients who had received oral other drugs, macular grid photocoagulation, intravitreal drug injection or vitrectomy within 3 months before treatment.
•(2) Patients with chronic fundus diseases. For example, glaucoma, optic atrophy, macular degeneration, diabetic retinopathy, moderate cataract and other eye diseases that seriously affect vision;
•(3) The refractive stroma is not clear, which affects the fundus observer.
•(4) Patients with severe systemic diseases.
•(5) Those who have taken other traditional Chinese medicine or drugs for promoting blood circulation and promoting diuresis within 14 days.
•(6) Mental disorders are difficult to cooperate with treatment.
•(7) The general condition is not suitable for the patients treated in this study protocol.

发起方

onghua Hospital Affiliated to Shanghai University of traditional Chinese Medicine